comparemela.com

Latest Breaking News On - Indian pharma market - Page 1 : comparemela.com

Ajanta Pharma Buyback: Should Investors Tender Their Shares?

Ajanta Pharma Buyback: Should Investors Tender Their Shares?
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

India Inc s earnings growth reverts to mean in the fourth quarter

Sai Prabhakar Yadavalli - bl. research bureau analyzes India Inc's Q4 performance and outlook for FY25.

Indian pharma market posts robust 9 5% growth in March

India s pharmaceutical market saw a 9.5% growth in March, reaching 16,158 crore in sales. The Moving Annual Total reached 197,976 crore with a 6.5% growth rate, with cardiology and anti-infectives among the top performers.

Sun Pharma scouting for innovative therapies to boost India business

Approved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, almost five times more than the narrow time window of 4-5 hours offered by current treatment options like tissue plasminogen activator (TPA) called thrombolytic drugs that dissolve the clots that cause strokes. An ischemic stroke is a medical emergency that occurs when blood supply to part of a brain is blocked or reduced.

Indian pharma market grows over 9 per cent in December

Among the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last month, according to data from research firm PharmaTrac. Antibiotic drug Augmentin and anti-diabetes Glycomet GP continued to be the top-selling medicine brands.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.